Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David R. Light
Evaluation of the Toxicology and Pharmacokinetics of Recombinant Factor VIII Fc Fusion Protein in Animals
Thrombosis Research
Hematology
Related publications
Indirect Comparison of the Efficacy of Recombinant Factor Viii Fc Fusion Protein and Other Factor Viii Products for ProphylaxisModeling the Effect of Compliance
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice
PLoS ONE
Multidisciplinary
Comparative Field Study: Impact of Laboratory Assay Variability on the Assessment of Recombinant Factor IX Fc Fusion Protein (rFIXFc) Activity
Thrombosis and Haemostasis
Hematology
A Single Chain Variant of Factor VIII Fc Fusion Protein Retains Normal in Vivo Efficacy but Exhibits Altered in Vitro Activity
PLoS ONE
Multidisciplinary
Evaluation of Recombinant Factor VIII Fc (Eloctate) Activity by Thromboelastometry in a Multicenter Phase 3 Clinical Trial and Correlation With Bleeding Phenotype
Blood Coagulation and Fibrinolysis
Medicine
Hematology
Prolonged Activity of Factor IX as a Monomeric Fc Fusion Protein
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Predicting FVIII Activity in Patients Who Use Recombinant FVIII Fc Fusion Protein for Prophylaxis and Treatment of Bleeding Episodes
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Performance of a Recombinant Fusion Protein Linking Coagulation Factor IX With Recombinant Albumin in One-Stage Clotting Assays
Journal of Thrombosis and Haemostasis
Medicine
Hematology
Intravenous Administration of Factor VIII–O-Phospho-L-Serine (OPLS) Complex Reduces Immunogenicity and Preserves Pharmacokinetics of the Therapeutic Protein
European Journal of Pharmaceutical Sciences
Pharmaceutical Science
